Beneficial Effects Of Perhexiline In Cardiovascular Disease States

by Chirkov , Sverdlov , YULIY Y. Chirkov, AARON L. Sverdlov and JOHN D. Horowitz

Subscribe to alerts

Paperback

Free delivery

Ships in 24-48 hours directly to you - Typically received in 10-15 working days after dispatch

IN STOCK

Ships in 24-48 hours directly to you - Typically received in 10-15 working days after dispatch

Online Price: $64.99

Be the first to like this

Learn More

You can use the 'like' button to provide positive feedback on products, reviews and other features on the website. 'Like' is similar to voting and will be used to present the most popular content. Once you have clicked 'like', you cannot 'unlike'. You can only 'like' something once.

Overview
Customer reviews

Related Products

Healthy Liver And Bowel Book

by Sandra Cabot

Online Price: $26.99

Campbell-Walsh Urology Review Manual

by Wein , Kavoussi , Andrew C. Novick and others

Online Price: $90.99

Urodynamics Made Easy

by Chapple , Macdiarmid , Christopher R. Chapple and others

Online Price: $60.99

Promoting Continence: A Clinical And Research Resource

by Getliffe , Dolman , Kathryn Getliffe and others

Online Price: $60.99

Fast Facts: Bladder Disorders

by Alan J. Wein, Diane K. Newman, Diane Kaschak Newman and others

Online Price: $31.99

Beneficial Effects Of Perhexiline In Cardiovascular Disease States

Synopsis

Perhexiline, 2-(2,2-dicyclohexylethyl) piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. It was initially a popular and effective treatment for angina, having the almost unique property compared to other agents available at that time, of not inducing reductions in blood pressure or heart rate. Despite the initial success, its use diminished markedly due to the occurrence during long-term therapy of poorly understood side effects (neurotoxicity and hepatotoxicity), which later were shown to be associated with high plasma concentrations of perhexiline, occurring in patients with relatively slow hepatic metabolism of the drug. However, therapeutic plasma monitoring and associated dose adjustments have led to perhexiline's reintroduction into clinical practice. This book discusses the benefits of perhexiline in the treatment of cardiovascular disease.